Feed Preview

Fragile X Syndrome

Fragile X Syndrome diagram by Emw, Wikimedia
Emw, Wikimedia

Fragile X syndrome is caused by an expanded CGG repeat (> 200 repeats) in the 5' untranslated portion of the fragile mental retardation 1 gene (FMR1) within the X chromosome, leading to deficiency of fragile X mental retardation protein (FMRP). It is cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. Intellectual disability occurs in nearly all males and roughly 50% of females with the full mutation. Discover the latest research on Fragile X syndrome here.

Top 20 most recent papers
Future Neurology

Fragile X- associated Neuropsychiatric Disorders: A Case Report

Future NeurologyFebruary 25, 2020
Maria Melinda TanRandi J Hagerman
JBRA Assisted Reproduction

First custom next-generation sequencing infertility panel in Latin America: design and first results

JBRA Assisted ReproductionMarch 11, 2020
Daniela LorenziSergio Papier

Genetic association of FMRP targets with psychiatric disorders

bioRxivFebruary 24, 2020
Nicholas E CliftonAndrew Pocklington
Frontiers in Molecular Biosciences

In silico, in vitro , and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome

Frontiers in Molecular BiosciencesMarch 29, 2020
Saif N HaifyGian Gaetano Tartaglia
Molecular Cell

Brain Translation: A Feather Tips the Scale

Molecular CellMarch 24, 2020
Dmytro UstianenkoChaolin Zhang
Biochemical and Biophysical Research Communications

MiR-315 is required for neural development and represses the expression of dFMR1 in Drosophila melanogaster

Biochemical and Biophysical Research CommunicationsFebruary 29, 2020
Liudi YuanMingkuan Sun

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

© 2020 Meta ULC. All rights reserved